Clinical Experience With Radiation Therapy in the Management of Neurofibromatosis-Associated Central Nervous System Tumors

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 1, 2009, Pages 208-213

  Wentworth, Stacy ^a   Pinn, Melva ^b   Bourland, J Daniel ^a   deGuzman, Allan F ^a   Ekstrand, Kenneth ^a   Ellis, Thomas L ^a   Glazier, Steven S ^a   McMullen, Kevin P ^a   Munley, Michael ^a   Stieber, Volker W ^a   Tatter, Stephen B ^a   Shaw, Edward G ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Acoustic neuroma; Meningioma; Neurofibromatosis; Radiation therapy; Radiosurgery

Indexed keywords

ACOUSTICS; COMPUTER OPERATING SYSTEMS; DOSIMETRY; GROWTH (MATERIALS); INFRARED SPECTROMETERS; ONCOLOGY; RADIOTHERAPY; SHELTERS (FROM ATTACK);

ACOUSTIC NEUROMA; MENINGIOMA; NEUROFIBROMATOSIS; RADIATION THERAPY; RADIOSURGERY;

TUMORS;

ACOUSTIC NEURINOMA; ADOLESCENT; ADULT; ARTICLE; CANCER GROWTH; CANCER RADIOTHERAPY; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EPENDYMOMA; FEMALE; FOLLOW UP; GLIOMA; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; NEURILEMOMA; NEUROFIBROMA; NEUROFIBROMATOSIS; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIATION DOSE; STEREOTACTIC RADIOSURGERY;

ADOLESCENT; ADULT; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; HUMANS; MIDDLE AGED; NEUROFIBROMATOSES; NORTH CAROLINA; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 57649087701     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.03.073     Document Type: Article

References (40)

1. Gutmann D.H., Aylsworth A., Carey J.C., et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278 (1994) 51-57
2. Evans D.G., Huson S.M., Donnai D., et al. A clinical study of type 2 neurofibromatosis. Q J Med 84 (1992) 603-618
3. Mautner V.F., Tatagiba M., Lindenau M., et al. Spinal tumors in patients with neurofibromatosis type 2: MR imaging study of frequency, multiplicity, and variety. AJR Am J Roentgenol 165 (1995) 951-955
4. Antinheimo J., Sankila R., Carpen O., et al. Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Neurology 54 (2000) 71-76
5. Mathieu D., Kondziolka D., Flickinger J.C., et al. Stereotactic radiosurgery for vestibular schwannomas in patients with neurofibromatosis type 2: An analysis of tumor control, complications and hearing preservation rates. Neurosurgery 60 (2007) 460-468
6. Rowe J.G., Radatz M.W.R., Walton L., et al. Clinical experience with Gamma Knife stereotactic radiosurgery in the management of vestibular schwannomas secondary to type 2 neurofibromatosis. J Neurol Neurosurg Psychiatry 74 (2003) 1288-1293
7. Kida Y., Koayashi T., Tanaka T., et al. Radiosurgery for bilateral neurinomas associated with neurofibromatosis type 2. Surg Neurol 53 (1999) 383-390
8. Listernick R., Frener R.E., Peirsall L., et al. Late-onset optic pathway tumors in children with neurofibromatosis 1. Neurology 63 (2004) 1944-1946
9. Balcer L., Lie G., Heller G., et al. Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: Relation to tumor location by magnetic resonance imaging. Am J Opthalmol 131 (2001) 442-445
10. Listernick R., Luois D., Packer R., et al. Optic pathway gliomas in children with neurofibromatosis 1: Consensus statement from NF1 Optic Pathway Glioma Task Force. Ann Neurol 41 (1997) 142-148
11. Astrup J. Natural history and clinical management of optic pathway glioma. Br J Neurosurg 17 (2003) 327-335
12. Danoff B.F., Kramer S., and Thompson N. The radiotherapeutic management of optic nerve gliomas in children. Int J Radiat Oncol Biol Phys 6 (1980) 45-50
13. Combs S.E., Schulz-Ertner D., Moschos D., et al. Fractionated stereotactic radiotherapy of optic pathway gliomas: Tolerance and long term outcome. Int J Radiat Oncol Biol Phys 62 (2005) 814-819
14. Saran F.H., Baumert B.G., Khoo V.S., et al. Stereotactically guided conformal radiotherapy for progressive low grade gliomas of childhood. Int J Radiat Oncol Biol Phys 53 (2002) 43-51
15. Marcus K.J., Goumenrvoa L., Billet A.L., et al. Stereotactic radiotherapy for localized low grade gliomas in children: Final results of a prospective trial. Int J Radiat Oncol Biol Phys 61 (2005) 374-379
16. Molloy P.T., Bilaniuk L.G., Vaughan S.N., et al. Brainstem tumors in patients with neurofibromatosis type 1: A distinct clinical entity. Neurology 45 (1995) 1897-1902
17. Schild S.E., Nist K., Scheithauer B.W., et al. The results of radiotherapy for ependymomas: The Mayo Clinic experience. Int J Radiat Oncol Biol Phys 42 (1998) 953-958
18. Merchant T.E., Mulhern R.K., Krasin M.J., et al. Preliminary results from a phase II trial of conformal radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymomas. J Clin Oncol 22 (2004) 3156-3162
19. Shaw E.G., Evans R.G., Scheithauer B.W., et al. Post operative radiotherapy of intracranial ependymoma in pediatric and adult patients. Int J Radiat Oncol Biol Phys 13 (1987) 1457-1462
20. Goldwein J.W., Leahy J.M., Packer R.J., et al. Intracranial ependymomas in children. Int J Radiat Oncol Biol Phys 19 (1990) 1497-1502
21. Baser M.E., Evans R., Gareth D., et al. Neurofibromatosis 2. Curr Opin Neurol 16 (2003) 27-33
22. Moffat D.A., Quaranta N., Baguley D.M., et al. Management strategies in neurofibromatosis type 2. Eur Arch Otorhinolaryngol 260 (2003) 12-18
23. Kalmarides M., Grayeli A.B., Bouccara D., et al. Hearing restoration with auditory brainstem implants after radiosurgery for neurofibromatosis type 2. J Neurosurg 95 (2001) 1028-1033
24. Flickinger J.C., Kondziolka D., Maitz A., et al. Gamma Knife radiosurgery of imaging diagnosed intracranial meningioma. Int J Radiat Oncol Biol Phys 54 (2003) 801-806
25. Pollock B.E., Stafford S.L., Utter A., et al. Stereotactic radiosurgery provides equivalent tumor control to Simpson grade 1 resection for patients with small to medium size meningiomas. Int J Radiat Oncol Biol Phys 55 (2003) 100-103
26. Sharif S., Ferner R., Birch J.M., et al. Second primary tumors in neurofibromatosis 1 patients treated for optic gliomas: Substantial risks after radiotherapy. J Clin Oncol 24 (2006) 2570-2575
27. Neglia J.P., Robison L.L., Stoval M., et al. New primary neoplasms of the central nervous system in survivors of childhood cancer: A report from the childhood cancer survivor study. J Natl Cancer Inst 98 (2006) 1528-1537
28. Evans D.G., Birch J.M., Ramsden R.T., et al. Malignant transformation and new primary tumors after therapeutic radiation for benign disease: Substantial risks in certain tumor prone syndromes. J Med Genet 43 (2006) 289-294
29. Brown P., and Shaw E.G. Low grade gliomas. In: Gunderson L., and Tepper J. (Eds). Clinical radiation oncology. 2nd ed. (2007), Churchill-Livingstone, Philadelphia 493-514
30. Ducatman B., Scheithauer B., Peipgras B., et al. Malignant peripheral nerve sheath rumors: A clinicopathological study of 120 patients. Cancer 57 (1986) 2006-2021
31. Needle M.N., Cnaan A., Dattilo J., et al. Prognostic signs in the surgical management of plexiform neurofibromas: The Children's Hospital of Philadelphia experience. 1974-1994. J Pediatr 131 (1997) 678-682
32. Chopra R., Morris C.G., Friedman W.A., et al. Radiotherapy and radiosurgery for benign neurofibromas. Am J Clin Oncol 28 (2005) 317-320
33. Greenburg H.M., Goebel R., Weichselbaum R.R., et al. Radiation therapy in the treatment of aggressive fibromatosis. Int J Radiat Oncol Biol Phys 7 (1981) 305-310
34. Suit H.D., and Russell W.O. Radiation therapy of soft tissue sarcoma. Cancer (1975) 36759-36764
35. Cawthon R.M., Weiss M., Xu G., et al. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure and point mutations. Cell 62 (1990) 193-201
36. Rouleau G.A., Merel P., Lutchman M., et al. Alteration in a new gene encoding a putative membrane organizing protein causes neurofibromatosis type 2. Nature 363 (1993) 515-521
37. Trofatter J.A., MacCollin M.M., Rutter J.L., et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72 (1993) 1-20
38. Babovic-Vuksanovic D., Ballman K., Michels V., et al. Phase II trial of pirfenidone in adults with neurofibromatosis type I. Neurology 67 (2006) 1860-1862
39. Gupta A., Cohen B.H., Ruggieri P., et al. Phase I study of thalidomide for the treatment of plexiform neurofibroma in neurofibromatosis 1. Neurology 60 (2003) 130-132
40. Widemann B.C., Salzer W.L., Arceci R.J., et al. Phase I trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib in children with refractory solid tumors or neurofibromatosis type I and plexiform neurofibromas. J Clin Oncol 24 (2006) 507-516